Matches in Nanopublications for { ?s ?p "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 24 of
24
with 100 items per page.
- NP521294.RAS87p-E1KFfEoiWYlEsBxhPuX7GcJy457Qg7PNb4i2f8130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP521294.RAS87p-E1KFfEoiWYlEsBxhPuX7GcJy457Qg7PNb4i2f8130_provenance.
- NP757957.RAROfOEp0UH4CEL2ylNlK-2Z4K_zk3eujC80hERHdm_G8130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP757957.RAROfOEp0UH4CEL2ylNlK-2Z4K_zk3eujC80hERHdm_G8130_provenance.
- NP236811.RAEJT3yXs6fXPExVi92O8_I5paqnUS5n_RbehS0O7lwDk130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP236811.RAEJT3yXs6fXPExVi92O8_I5paqnUS5n_RbehS0O7lwDk130_provenance.
- NP624896.RAf80H84AGGg97WnYVQk9iIuqVqRZZ8hqCSSEwZ16c-n4130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624896.RAf80H84AGGg97WnYVQk9iIuqVqRZZ8hqCSSEwZ16c-n4130_provenance.
- NP621041.RAesl7tqwewqe_TwOUuto37WKD4Rk32kFZEcZI2gq6C3A130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621041.RAesl7tqwewqe_TwOUuto37WKD4Rk32kFZEcZI2gq6C3A130_provenance.
- assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1035648.RARfJzjIGI7RppziPOxCU-j62w04NipW_4As2yeii2v90130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1035648.RARfJzjIGI7RppziPOxCU-j62w04NipW_4As2yeii2v90130_provenance.
- NP1035653.RAX1_QPIlWyAZXK6CH7pRMjzdNGp-TqAIOMz_ean92Iso130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1035653.RAX1_QPIlWyAZXK6CH7pRMjzdNGp-TqAIOMz_ean92Iso130_provenance.
- NP623212.RABgKenCpyCVBz9NuNadFa5MvnPgZeOk3OTBJVPENf5Uk130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623212.RABgKenCpyCVBz9NuNadFa5MvnPgZeOk3OTBJVPENf5Uk130_provenance.
- NP623758.RAAWrYoh3j-lqnEOmlEr735M8fZ37o8tFa8ks646Wxpi8130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623758.RAAWrYoh3j-lqnEOmlEr735M8fZ37o8tFa8ks646Wxpi8130_provenance.
- NP625672.RABOBpDctzVrAVL6pMG3UJYww80Rd3HO7Pa0NvJMjEPyI130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625672.RABOBpDctzVrAVL6pMG3UJYww80Rd3HO7Pa0NvJMjEPyI130_provenance.
- NP1035656.RACYmbNyattCPVcOya_bZncJj7ikNs34GM7n_Um0dKZjs130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1035656.RACYmbNyattCPVcOya_bZncJj7ikNs34GM7n_Um0dKZjs130_provenance.
- NP500458.RAlXS2ZFj4ZXNasRKX77iGhLUQzhDZvl3vkJVLHrr13ew130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500458.RAlXS2ZFj4ZXNasRKX77iGhLUQzhDZvl3vkJVLHrr13ew130_provenance.
- NP622073.RAk32Qyt0btblJPbAQvzYPd9S5v64jflYgYWRKH6G0ucQ130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622073.RAk32Qyt0btblJPbAQvzYPd9S5v64jflYgYWRKH6G0ucQ130_provenance.
- NP622446.RAmoHQ_EAYaYHjH6iqaJjhqQ2ujikUbusQKwXgUxICGLA130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622446.RAmoHQ_EAYaYHjH6iqaJjhqQ2ujikUbusQKwXgUxICGLA130_provenance.
- NP624529.RAnT8dusrQUyu0_LViUf86RUcq7CJpJ9l8BUp_065rBX0130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624529.RAnT8dusrQUyu0_LViUf86RUcq7CJpJ9l8BUp_065rBX0130_provenance.
- NP1035649.RAkpYqC7P02y7VGkmdPDvbK7S0805gl9qYxZte-FN5mkU130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1035649.RAkpYqC7P02y7VGkmdPDvbK7S0805gl9qYxZte-FN5mkU130_provenance.
- NP1035650.RAkLg_BGW7qh86GQD9WP0Xf_XOpLH5EwBrpPnU3XBmo4U130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1035650.RAkLg_BGW7qh86GQD9WP0Xf_XOpLH5EwBrpPnU3XBmo4U130_provenance.
- NP1035655.RAonaz4i_IIDdN7Rf7dlBIuV7ciGoehIqqKtjNMNnbuek130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1035655.RAonaz4i_IIDdN7Rf7dlBIuV7ciGoehIqqKtjNMNnbuek130_provenance.
- NP1035657.RAqboNHiDPWH4vuxhTH4FQMF8rBD1fBKJ0MQielnRvxoo130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1035657.RAqboNHiDPWH4vuxhTH4FQMF8rBD1fBKJ0MQielnRvxoo130_provenance.
- NP500279.RAzkyrNQ-susFX2a_CUOsp1KJyaeZsa6AW5YTitfUI3kQ130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500279.RAzkyrNQ-susFX2a_CUOsp1KJyaeZsa6AW5YTitfUI3kQ130_provenance.
- NP1035651.RALKJzT7GMqPdDG64amsMgat7pkPxE8WBd0lSHYP1C0FM130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1035651.RALKJzT7GMqPdDG64amsMgat7pkPxE8WBd0lSHYP1C0FM130_provenance.
- NP1035652.RAMPck65LlctBnltneCUUgFXiYfgwh6-5mn7_uPS67UI8130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1035652.RAMPck65LlctBnltneCUUgFXiYfgwh6-5mn7_uPS67UI8130_provenance.
- NP1035654.RA-VEUs4kfb8An3slEmuN6FGLUqLmPLuhP1IefH3CWhLc130_assertion description "[Here, we review the data on the involvement of IL-7 and IL-7R in T-ALL, further discussing the peculiarities of IL-7R-mediated signaling in human leukemia T-cells that may be of therapeutic value, namely regarding the potential use of PI3K and mTOR pharmacological inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1035654.RA-VEUs4kfb8An3slEmuN6FGLUqLmPLuhP1IefH3CWhLc130_provenance.